Cargando…

Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life

Indomethacin is used commonly in preterm neonates for the prevention of intracranial hemorrhage and closure of an abnormally open cardiac vessel. Due to biomedical advances, the infants who receive this drug in the neonatal intensive care unit setting have become younger, smaller, and less mature (m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzyzanski, Wojciech, Stockard, Bradley, Gaedigk, Andrea, Scott, Allison, Nolte, Whitney, Gibson, Kim, Leeder, J. Steven, Lewis, Tamorah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835126/ https://www.ncbi.nlm.nih.gov/pubmed/36309972 http://dx.doi.org/10.1002/psp4.12881

Ejemplares similares

Intensive and Prolonged Urine Collection in Preterm Infants Reveals Three Distinct Indomethacin Metabolic Patterns: Potential Implications for Drug Dosing
por: Lewis, Tamorah, et al.
Publicado: (2018)

Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
por: Stockard, Bradley, et al.
Publicado: (2022)

Lifespan Based Pharmacokinetic-Pharmacodynamic Model of Tumor Growth Inhibition by Anticancer Therapeutics
por: Mo, Gary, et al.
Publicado: (2014)

LBODP083 Pharmacokinetics Of Metformin In Obese Non-diabetic Youth: Drug Clearance Increases With Severity Of Obesity
por: Halpin, Kelsee, et al.
Publicado: (2022)

Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy
por: Alqahtani, Saeed, et al.
Publicado: (2015)

Minimal physiologically‐based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids
por: Krzyzanski, Wojciech, et al.
Publicado: (2023)

Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
por: Pacifici, Gian Maria
Publicado: (2014)

Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-Analysis
por: Al-matary, Abdulrahman, et al.
Publicado: (2022)

Model for Severe Intracranial Hemorrhage and Role of Early Indomethacin in Extreme Preterm Infants
por: Chawla, Sanjay, et al.
Publicado: (2022)

Differential effects of ibuprofen and indomethacin on cerebral oxygen kinetics in the very preterm baby
por: Stark, Michael J., et al.
Publicado: (2022)

Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants
por: Butranova, Olga I., et al.
Publicado: (2023)

Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin
por: Gillam-Krakauer, Maria, et al.
Publicado: (2020)

A Predictive Model for SIVH risk in Preterm Infants and Targeted Indomethacin Therapy for Prevention
por: Singh, Rachana, et al.
Publicado: (2013)

Pharmacometabolomics of Respiratory Phenotypic Response to Dexamethasone in Preterm Infants at Risk for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2019)

Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women
por: Krzyzanski, Wojciech, et al.
Publicado: (2021)

The effectiveness of nifedipine/indomethacin combination therapy and nifedipine monotherapy for postponing preterm birth (25–34 weeks of gestation) in Sudanese women: a randomized clinical trial study protocol
por: Ibrahim, Mohammed H., et al.
Publicado: (2021)

Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities
por: Dinh, Jean, et al.
Publicado: (2023)

Change in Blood Pressure and Pulse Pressure in Preterm Infants After Treatment of Patent Ductus Arteriosus With Indomethacin
por: Han, Ui Joung, et al.
Publicado: (2011)

Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients
por: Smuszkiewicz, Piotr, et al.
Publicado: (2017)

Massive Gastric Hemorrhage after Indomethacin Therapy: A Rare Presentation and Critical Management in an Extremely Preterm Infant
por: Chen, Yen-Ju, et al.
Publicado: (2021)

Formulation and evaluation of indomethacin biomicroparticles
por: Gupta, Sudeep, et al.
Publicado: (2012)

Indomethacin-Induced Hypertensive Crisis
por: Dhungana, Bibek, et al.
Publicado: (2021)

Prediction of CYP2D6 phenotype from genotype across world populations
por: Gaedigk, Andrea, et al.
Publicado: (2017)

Ten Years’ Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia
por: Wagner, Jonathan B., et al.
Publicado: (2020)

Long-Distance Phasing of a Tentative “Enhancer” Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions
por: Boone, Erin C., et al.
Publicado: (2020)

Chlorogenic Acid Protects Against Indomethacin-Induced Inflammation and Mucosa Damage by Decreasing Bacteroides-Derived LPS
por: Yan, Yongwang, et al.
Publicado: (2020)

Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports
por: Matsumura, Shun, et al.
Publicado: (2017)

Multi-scale model of drug induced adaptive resistance of Gram-negative bacteria to polymyxin B
por: Krzyzanski, Wojciech, et al.
Publicado: (2017)

A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
por: Summ, Oliver, et al.
Publicado: (2010)

Genetic Variation in CRHR1 is Associated with Short-Term Respiratory Response to Corticosteroids in Preterm Infants at risk for Bronchopulmonary Dysplasia
por: Lewis, Tamorah, et al.
Publicado: (2018)

Effects of prophylactic indomethacin on morbidity and mortality in infants <25 weeks’ gestation: a protocol driven intention to treat analysis
por: Clyman, Ronald I., et al.
Publicado: (2022)

Preparation and in-vitro evaluation of indomethacin nanoparticles
por: Rezaei Mokarram, A., et al.
Publicado: (2010)

Hybrid Nanobeads for Oral Indomethacin Delivery
por: Bonetti, Flávia Monique Rocha, et al.
Publicado: (2022)

Predicting human pharmacokinetics from preclinical data: clearance
por: Yim, Dong-Seok, et al.
Publicado: (2021)

Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation
por: Jannatdoust, Abdollah, et al.
Publicado: (2014)

A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants
por: AlFaleh, Khalid, et al.
Publicado: (2015)

Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates – A randomized controlled trial
por: Meena, Vasudha, et al.
Publicado: (2020)

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
por: Oshima, Ayumi, et al.
Publicado: (2020)

Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h4s8ri5gq98bui76p4ujq6v2uq